Formulation and storage of platelet-rich plasma homemade product.

Olivier Bausset, Laurent Giraudo, Julie Veran, Jeremy Magalon, Jean-Marie Coudreuse, Guy Magalon, Christophe Dubois, Nicolas Serratrice, Françoise Dignat-George, Florence Sabatier
Author Information
  1. Olivier Bausset: Cell Therapy Unit, CHU Conception , Marseille, France .

Abstract

The platelet-rich plasma (PRP) is an autologous biotherapy based on platelet-healing properties. Here, we developed a simple and reproducible PRP purification protocol based on two successive centrifugations. We evaluated different centrifugation speeds and time-storage durations on the platelet quantity and quality. Sterility and stability of our PRP homemade product were also performed. We prepared PRP from 54 healthy volunteers. We tested activation state, reactivity, and stability of platelets by flow cytometry using basal and adenosine diphosphate (ADP)-induced P-selectin expression markers; growth factor release after platelet activation by an enzyme-linked immunosorbent assay (ELISA); platelet aggregation capacity by aggregrometry assays; clot formation and retraction by thromboelastography; and platelet morphology by ultrastructural analysis. About 130 and 250 g successive speed centrifugations further concentrated platelets while preserving their bioactivity during 6 h (after that, platelet functions were significantly altered). In these conditions, we obtained a highly concentrated pure PRP product (with a low leukocyte count) suitable to study platelet properties. To avoid the loss of efficacy, we recommend injecting PRP under 3 h after preparation.

References

  1. JAMA. 2010 Jan 13;303(2):144-9 [PMID: 20068208]
  2. Clin Oral Implants Res. 2003 Jun;14(3):357-62 [PMID: 12755786]
  3. Br J Pharmacol. 2005 Nov;146(6):882-93 [PMID: 16158070]
  4. Clin Lab Haematol. 2005 Apr;27(2):81-90 [PMID: 15784122]
  5. Transfus Apher Sci. 2002 Jun;26(3):147-55 [PMID: 12126199]
  6. J Biomed Mater Res A. 2010 Dec 15;95(4):1280-2 [PMID: 20925082]
  7. Am J Sports Med. 2006 Nov;34(11):1774-8 [PMID: 16735582]
  8. J Clin Lab Anal. 1995;9(2):138-40 [PMID: 7714666]
  9. J Oral Maxillofac Surg. 2000 Mar;58(3):297-300; discussion 300-1 [PMID: 10716112]
  10. J Plast Reconstr Aesthet Surg. 2011 Feb;64(2):e31-9 [PMID: 20884308]
  11. Br J Haematol. 1976 Nov;34(3):403-19 [PMID: 10956]
  12. Am J Sports Med. 2011 Jun;39(6):1200-8 [PMID: 21422467]
  13. J Orthop Res. 2008 Mar;26(3):404-10 [PMID: 17960651]
  14. J Orthop Res. 2010 Nov;28(11):1448-55 [PMID: 20872580]
  15. Transfus Apher Sci. 2009 Oct;41(2):97-104 [PMID: 19699153]
  16. J Craniomaxillofac Surg. 2002 Apr;30(2):97-102 [PMID: 12069512]
  17. Vox Sang. 2005 Apr;88(3):153-63 [PMID: 15787725]
  18. Am J Sports Med. 2010 Feb;38(2):255-62 [PMID: 20448192]
  19. Br J Pharmacol. 2004 Jan;141(2):241-52 [PMID: 14691052]
  20. Cell Prolif. 2009 Apr;42(2):162-70 [PMID: 19250293]
  21. Transfusion. 2007 Apr;47(4):653-65 [PMID: 17381624]

Word Cloud

Created with Highcharts 10.0.0PRPplateletproductplatelet-richplasmabasedpropertiessuccessivecentrifugationsstabilityhomemadeactivationplateletsconcentratedautologousbiotherapyplatelet-healingdevelopedsimplereproduciblepurificationprotocoltwoevaluateddifferentcentrifugationspeedstime-storagedurationsquantityqualitySterilityalsoperformedprepared54healthyvolunteerstestedstatereactivityflowcytometryusingbasaladenosinediphosphateADP-inducedP-selectinexpressionmarkersgrowthfactorreleaseenzyme-linkedimmunosorbentassayELISAaggregationcapacityaggregrometryassaysclotformationretractionthromboelastographymorphologyultrastructuralanalysis130250gspeedpreservingbioactivity6 hfunctionssignificantlyalteredconditionsobtainedhighlypurelowleukocytecountsuitablestudyavoidlossefficacyrecommendinjecting3 hpreparationFormulationstorage

Similar Articles

Cited By (38)